Tariffs, Trump, and Turmoil
Motley Fool Money
Market Trends and Innovations
This chapter covers significant developments in the stock market, particularly focusing on Dexcom's FDA approval of the G7 glucose monitor and its competitive dynamics with other companies. The discussion also delves into investment opportunities presented by both Dexcom and Robinhood, highlighting the impact of new technologies and generational shifts in investing.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
